Yi‐Hao Chiang

Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms

Yu‐Cheng Chang, Huan‐Chau Lin, Yi‐Hao Chiang et al. · Medical Oncology · 2017 · 47 citations

Hematological Malignancy, Medicine, Novel Mutations +7

CD5 deletion enhances the antitumor activity of adoptive T cell therapies

Ruchi P. Patel, Guido Ghilardi, Yunlin Zhang et al. · Science Immunology · 2024 · 41 citations · Full text

CRISPR-Cas9 Knock out of CD5 Enhances the Anti-Tumor Activity of Chimeric Antigen Receptor T Cells

Inkook Chun, Ki Hyun Kim, Yi‐Hao Chiang et al. · Blood · 2020 · 26 citations

Rapid and sensitive detection of CALR exon 9 mutations using high-resolution melting analysis

Ken‐Hong Lim, Huan‐Chau Lin, Caleb Gon‐Shen Chen et al. · Clinica Chimica Acta · 2014 · 20 citations

Sensitive Detection, High-resolution Melting Analysis, Engineering +10

Germline variations at <i>JAK2</i>, <i>TERT</i>, <i>HBS1L-MYB</i> and <i>MECOM</i> and the risk of myeloproliferative neoplasms in Taiwanese population

Yi‐Hao Chiang, Yu‐Cheng Chang, Huan‐Chau Lin et al. · Oncotarget · 2017 · 13 citations · Full text